| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.1M | -52.5% |
| SG&A Expense | $10.6M | -4.6% |
| Operating Income | -$15.7M | +28.2% |
| Pre-tax Income | -$15.2M | +29.8% |
| Net Income | -$15.2M | +29.8% |
| EPS (Basic) | -$12.97 | -601.1% |
| EPS (Diluted) | -$12.97 | -601.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Current Assets | $9.6M | -51.1% |
| Total Assets | $9.6M | -51.1% |
| Current Liabilities | $7.7M | +148.6% |
| Total Liabilities | $7.7M | +148.6% |
| Stockholders' Equity | $1.9M | -88.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.9M | +44.8% |